Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Study compares pulse vs. continuous therapy for dermatophyte toenail onychomycosis
- Author:
- Doug Brunk
“In both therapies, it may be that residual spores that have not been eliminated by the end of therapy are left to germinate, possibly...
News
Study spotlights the skin microbiome’s evolving nature
- Author:
- Doug Brunk
The increase in skin microbiome diversity observed in the children is likely due to a variety of factors, including inherent growth and...
News
Results from two phase 3 trials of bimekizumab unveiled
- Author:
- Doug Brunk
Bimekizumab selectively inhibits IL-17A and IL-17F, two key cytokines that drive inflammation and tissue damage across multiple diseases.
News
Clinicians urged to use CURE ID to report COVID-19 cases
- Author:
- Doug Brunk
A total of 65 repurposed drugs have been identified as potential treatments for the virus, including 15 drugs with 10 or more cases.
News
Former smokers using e-cigarettes at risk for cigarette smoking relapse
- Author:
- Doug Brunk
“Determining pharmacologic, behavioral, or some other explanation for these findings may require laboratory-based research,” the authors wrote.
News
Low IgG levels in COPD patients linked to increased risk of hospitalization
- Author:
- Doug Brunk
“Our results raise the possibility that, in select COPD patients, IgG replacement therapy may be effective in reducing the risk of COPD...
News
Latest from ISCHEMIA: Worse outcomes in patients with intermediate left main disease on CCTA
- Author:
- Doug Brunk
Patients in the ISCHEMIA trial with intermediate LMD identified by coronary CT angiography had more procedural MIs, but fewer later ones.
Aesthetic Dermatology
Authors of picosecond laser review predict more widespread use of the technology
- Author:
- Doug Brunk
“Future directions may include the development of even shorter pulse durations, improvements in fractionation method and delivery, and exploration...
News
Immunotherapy, steroids had positive outcomes in COVID-19–associated multisystem inflammatory syndrome
- Author:
- Doug Brunk
“Incomplete forms of Kawasaki disease occur in infants who may have fever as the sole clinical finding, whereas older patients are more prone to...
News
To fast or not to fast before elective cardiac catheterization
- Author:
- Doug Brunk
No restriction of oral intake is deemed just as safe as traditional NPO strategy prior to nonemergent cardiac...
News
With massive reach, telemedicine transforms STEMI care in Latin America
- Author:
- Doug Brunk
“If I am able to guide a patient in Mexico from Bogotá, Colombia, it should be easy to guide a patient from Miami who’s presenting in Zambia,” Dr...
Aesthetic Dermatology
Experts recommend slow, steady approach to reopening laser and cosmetic surgery practices
- Author:
- Doug Brunk
“This is not the time for shortcuts,” Dr. Jeffrey S. Dover said.
News
With life in the balance, a pediatric palliative care program expands its work to adults
- Author:
- Doug Brunk
“It brings up feelings like I had after 9/11 – a unified approach to surviving this as people, as a community, the idea that ‘we will get through...
News
In COVID-19 era: Infusion centers shuffle services
- Author:
- Doug Brunk
At the infusion centers operated by the ...
News
Primary care physicians reshuffle their work, lives in a pandemic
- Author:
- Doug Brunk
“Our knowledge of this disease is five steps behind, and changing at lightning speed,” said Dr. MaryAnn Dakkak.